- call +1-201-465-4211
- email sales@mrinsights.biz
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
Scope of the Report:
This report focuses on the Soliris Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Soliris Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Alexion
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Plasma Exchange
Plasma Infusion
Market Segment by Applications, can be divided into
PNH
aHUS
Other
There are 15 Chapters to deeply display the global Soliris Drug market.
Chapter 1, to describe Soliris Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Soliris Drug, with sales, revenue, and price of Soliris Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Soliris Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Soliris Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Soliris Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Soliris Drug Introduction
1.2 Market Analysis by Type
1.2.1 Plasma Exchange
1.2.2 Plasma Infusion
1.3 Market Analysis by Applications
1.3.1 PNH
1.3.2 aHUS
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Alexion
2.1.1 Business Overview
2.1.2 Soliris Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Alexion Soliris Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Soliris Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Soliris Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Soliris Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Soliris Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Soliris Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Soliris Drug Market Analysis by Regions
4.1 Global Soliris Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Soliris Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Soliris Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Soliris Drug Sales and Growth Rate (2013-2018)
4.3 Europe Soliris Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Soliris Drug Sales and Growth Rate (2013-2018)
4.5 South America Soliris Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Soliris Drug Sales and Growth Rate (2013-2018)
5 North America Soliris Drug by Countries
5.1 North America Soliris Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Soliris Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Soliris Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Soliris Drug Sales and Growth Rate (2013-2018)
5.3 Canada Soliris Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Soliris Drug Sales and Growth Rate (2013-2018)
6 Europe Soliris Drug by Countries
6.1 Europe Soliris Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Soliris Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Soliris Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Soliris Drug Sales and Growth Rate (2013-2018)
6.3 UK Soliris Drug Sales and Growth Rate (2013-2018)
6.4 France Soliris Drug Sales and Growth Rate (2013-2018)
6.5 Russia Soliris Drug Sales and Growth Rate (2013-2018)
6.6 Italy Soliris Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Soliris Drug by Countries
7.1 Asia-Pacific Soliris Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Soliris Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Soliris Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Soliris Drug Sales and Growth Rate (2013-2018)
7.3 Japan Soliris Drug Sales and Growth Rate (2013-2018)
7.4 Korea Soliris Drug Sales and Growth Rate (2013-2018)
7.5 India Soliris Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Soliris Drug Sales and Growth Rate (2013-2018)
8 South America Soliris Drug by Countries
8.1 South America Soliris Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Soliris Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Soliris Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Soliris Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Soliris Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Soliris Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Soliris Drug by Countries
9.1 Middle East and Africa Soliris Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Soliris Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Soliris Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Soliris Drug Sales and Growth Rate (2013-2018)
9.3 UAE Soliris Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Soliris Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Soliris Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Soliris Drug Sales and Growth Rate (2013-2018)
10 Global Soliris Drug Market Segment by Type
10.1 Global Soliris Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Soliris Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Soliris Drug Revenue and Market Share by Type (2013-2018)
10.2 Plasma Exchange Sales Growth and Price
10.2.1 Global Plasma Exchange Sales Growth (2013-2018)
10.2.2 Global Plasma Exchange Price (2013-2018)
10.3 Plasma Infusion Sales Growth and Price
10.3.1 Global Plasma Infusion Sales Growth (2013-2018)
10.3.2 Global Plasma Infusion Price (2013-2018)
11 Global Soliris Drug Market Segment by Application
11.1 Global Soliris Drug Sales Market Share by Application (2013-2018)
11.2 PNH Sales Growth (2013-2018)
11.3 aHUS Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)
12 Soliris Drug Market Forecast (2018-2023)
12.1 Global Soliris Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Soliris Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Soliris Drug Market Forecast (2018-2023)
12.2.2 Europe Soliris Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Soliris Drug Market Forecast (2018-2023)
12.2.4 South America Soliris Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Soliris Drug Market Forecast (2018-2023)
12.3 Soliris Drug Market Forecast by Type (2018-2023)
12.3.1 Global Soliris Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Soliris Drug Market Share Forecast by Type (2018-2023)
12.4 Soliris Drug Market Forecast by Application (2018-2023)
12.4.1 Global Soliris Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Soliris Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Soliris Drug Picture
Table Product Specifications of Soliris Drug
Figure Global Sales Market Share of Soliris Drug by Types in 2017
Table Soliris Drug T
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
